abs29.txt	malignant	pleural	mesothelioma	(mpm)	is	a	highly	lethal	cancer	of	the	lining	ofthe	chest	cavity		to	expand	our	understanding	of	mpm		we	conducted	acomprehensive	integrated	genomic	study		including	the	most	detailed	analysis	ofbap1	alterations	to	date		we	identified	histology-independent	molecularprognostic	subsets		and	defined	a	novel	genomic	subtype	with	tp53	and	setdb1mutations	and	extensive	loss	of	heterozygosity		we	also	report	strong	expressionof	the	immune	checkpoint	gene	vista	in	epithelioid	mpm		strikingly	higher	than	inother	solid	cancers		with	implications	for	the	immune	response	to	mpm	and	for	itsimmunotherapy		our	findings	highlight	new	avenues	for	further	investigation	ofmpm	biology	and	novel	therapeutic	options	
